Clinical Trial Update: Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

NCI-sponsored Phase 1/2 trial of mithramycin in children and adults with solid tumors or Ewing sarcoma was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Sarcoma

Drugs mentioned

• Mithramycin (mithramycin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ewing Sarcoma, Sarcoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-02-15